Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts - «Национальный агрегатор открытых репозиториев российских университетов» (НОРА)

Материалов:
1 005 012

Репозиториев:
30

Авторов:
761 409

расширенный поиск

Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts

Kobalava J.D., Gurevich V.S., Galyavich A.M., Kaminnyi A.I., Kashtalap V.V., Mareev V.Y., Susekov A.V., Shaposhnik I.I.

Дата публикации в реестре: 2021-08-05T19:44:12Z

Аннотация:

Тип: Article

Права: open access

Источник: Kardiologiia

Другие версии документа

Possibilities of clinical use of ezetimibe Otrio (JSC “AKRIKHIN”, Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts

Связанные документы (рекомендация CORE)